CytRx Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology

by Eddie Staley, Benzinga Editor
April 12, 2012 8:30 AM | 11 seconds read |
CytRx Corporation CYTR today announced that the U.S. Patent and Trademark Office (USPTO) has issued a key patent covering the tumor-targeting conjugate INNO-206 linker platform technology and INNO-206 pharmaceutical compositions.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!